Oxaliplatin Active Pharmaceutical Ingredient — Class II drug recall D-1882-2019
Terminated recall by Johnson Matthey Inc., reported 2019-10-02, distributed nationwide. cGMP Deviations: Potential glass contamination
| Recall number | D-1882-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Johnson Matthey Inc., West Deptford, NJ, United States |
| Recall initiated | 2019-08-29 |
| Classified | 2019-09-25 |
| Reported by FDA | 2019-10-02 |
| Terminated | 2022-01-21 |
| Distributed | Nationwide (US) |
| Quantity | 316,703.32 |
| Reason classes | foreign material, cgmp |
| Lot numbers | B0126-170701, B0126-170802, B0126-180401, B0126-180702, B0126-180803 |
| Expiration dates | 2022-09-20, 2023-05-20, 2023-10-20 |
Product
Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX
Reason for recall
cGMP Deviations: Potential glass contamination
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1882-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.